Academician sang Guowei won the lifetime achievement award of Chinese pharmaceutical innovation

Source: China pharmaceutical innovation promotion association March 13, 2017 The awarding ceremony of the second (2016) China pharmaceutical innovation brand series selection activity (hereinafter referred to as the selection activity) jointly sponsored by the Chinese Academy of Medical Sciences, the Chinese Academy of traditional Chinese medicine, the China Pharmaceutical Innovation Promotion Association (hereinafter referred to as the "China pharmaceutical promotion association") and people's network was held in Beijing on March 12, 2017 According to the unanimous recommendation of experts from the evaluation expert committee of this selection activity, academician sang Guo, vice chairman of the Standing Committee of the 11th National People's Congress and chief engineer of major special technology of national major new drug creation science and technology, won the "lifetime achievement award of Chinese medicine creation" More than 160 guests, including leaders at all levels, well-known experts, scholars and entrepreneurs from the regulatory authorities of the pharmaceutical industry, witnessed the award of academician sang Guowei Vice chairman Chen Zhu presented awards to academician sang Guowei Liu Qian, former deputy director of the national health and Family Planning Commission, read out the award speech, which highly praised the outstanding contribution made by academician sang Guowei in drug research and development and promoting China's pharmaceutical innovation In particular, he pointed out that "academician sang Guowei promotes China's establishment of GLP and GCP platforms in line with international standards, improves the pharmaceutical industry's innovative drug research and development capacity, and promotes the national pharmaceutical innovation system It has made important contributions to the construction and improvement of the policy environment for pharmaceutical innovation and development When Comrade Liu Qian announced that the winner of "lifetime achievement award of Chinese pharmaceutical innovation" was academician sang Guowei, thunderous applause broke out Chen Zhu, vice chairman of the Standing Committee of the National People's Congress and chairman of the Central Committee of the rural labor party, personally awarded the honorary certificate to academician sang Guowei Academician sang Guowei was very excited when he delivered his award speech He said that he was very glad to catch up with a great era The CPC Central Committee and the State Council took innovation as the driving force for social and economic development and attached great importance to the role of intellectuals As the chief technical engineer of major special projects in the 11th five year plan, 12th Five Year Plan and 13th five year plan, he said, "it is my lifelong wish to promote China's pharmaceutical innovation, and it is my lifelong dream to make China a powerful country in pharmaceutical innovation." Participants congratulated academician sang Guowei on his award-winning efforts in China's pharmaceutical R & D and industry management for more than 50 years Academician sang Guowei made outstanding contributions to promoting China's pharmaceutical innovation As a scientist, he led the development of a new class II drug, compound heptanone, which was recommended by who as one of the two best contraceptives for injection in 1994; in the early 1990s, he took the lead in designing and presiding over a randomized, controlled, multicenter clinical trial involving 14000 patients with misoprostol and mifepristone for emergency contraceptives in China, and presided over the formulation of the drug termination of early pregnancy routine in China China Japan JICA long-term cooperation project, the construction of national drug safety evaluation center, has made an important contribution to the establishment of GLP and GCP platforms in line with international standards in China As a social activist, he has repeatedly led the relevant departments and comrades of the National People's Congress, the agricultural labor party and the China Council for the promotion of drugs to jointly carry out policy research and industrial hot spot research, put forward suggestions for the government departments, provide strategic advice for the development of the industry, and make important contributions to promoting the improvement of policy environment for pharmaceutical innovation As a leader, especially as the group leader and chief science of the "1035" major special "innovative drugs and modernization of traditional Chinese medicine" general expert group of the Ministry of science and technology, and as the chief technology engineer of the national "major new drug creation" major special science and technology in the 11th, 12th and 13th five years since 2008, he always takes his keen insight into the development direction of pharmaceutical innovation as the special technology development strategy , development planning and stage implementation plan to grasp the overall technical direction, in order to promote the construction of drug innovation and R & D platform in China, accelerate the industry transformation from imitation to innovation and enhance the international level, and make important contributions to the construction of the national pharmaceutical innovation system with enterprises as the main body Now, academician sang Guowei is over 70 years old, still concerned about people's health, and insists on unremitting efforts for pharmaceutical innovation, which deserves the honor.